Connor, Clark & Lunn Investment Management Ltd. Regenxbio Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 61,288 shares of RGNX stock, worth $519,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,288
Holding current value
$519,109
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$10.49 - $14.39 $642,911 - $881,934
61,288 New
61,288 $642,000
Q2 2022

Aug 05, 2022
SELL
$19.35 - $35.04 $865,931 - $1.57 Million
-44,751 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$24.62 - $34.31 $515,444 - $718,314
-20,936 Reduced 31.87%
44,751 $1.49 Million
Q4 2021

Feb 10, 2022
SELL
$30.19 - $40.28 $347,034 - $463,018
-11,495 Reduced 14.89%
65,687 $2.15 Million
Q3 2021

Nov 12, 2021
BUY
$29.09 - $45.68 $2.25 Million - $3.53 Million
77,182 New
77,182 $3.24 Million
Q4 2018

Feb 12, 2019
SELL
$39.11 - $75.15 $299,778 - $576,024
-7,665 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$65.0 - $82.15 $498,225 - $629,679
7,665 New
7,665 $579,000

Others Institutions Holding RGNX

# of Institutions
197
Shares Held
43.2M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $366M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email